Regeneron

All the email addresses for regeneron.com
288 email addresses
{first}.{last}@regeneron.com
20+ sources
http://prnewswire.com/news-releases/sanofi-and-regeneron-to-present-alirocumab-clinical-data-at-the-american-college-of-cardiologys-63rd-annual-scientific-session-252586521.html May 5, 2015
http://drugs.com/clinical_trials/sanofi-regeneron-cuts-ldl-phase-iii-study-16197.html October 10, 2016
http://bio-medicine.org/medicine-technology-1/sanofi-and-regeneron-announce-patient-enrollment-in-two-phase-3-trials-with-sarilumab-in-rheumatoid-arthritis--28ra-29-32962-1 June 6, 2017
http://mediaroom.sanofi.com/sanofi-sanofi-et-regeneron-vont-presenter-des-donnees-cliniques-sur-lalirocumab-aux-63emes-seances-scientifiques-annuelles-de-lamerican-college-of-cardiology-2 August 8, 2017
http://frenchbiobeach.com/category/biotech-news/page/4 April 4, 2016
http://frenchbiobeach.com/2013/11/23/sanofi-and-regeneron-report-positive-results-with-sarilumab-in-first-phase-3-rheumatoid-arthritis-registration-trial April 4, 2016
http://mediaroom.sanofi.com/sanofi-sanofi-and-regeneron-to-present-alirocumab-clinical-data-at-american-college-of-cardiology-63rd-annual-scientific-session July 7, 2017
http://drugs.com/clinical_trials/sanofi-regeneron-report-positive-results-sarilumab-16345.html October 10, 2016
http://biospace.com/news/sanofi-france-and-regeneron-pharmaceuticals-inc/296756 January 1, 2015
http://biospace.com/news/regeneron-pharmaceuticals-inc-and-bayer-healthcare/304920 January 1, 2015
http://biospace.com/news/sanofi-france-and-regeneron-pharmaceuticals-inc/319187 January 1, 2015
http://macularhope.org/regeneron-highlights-eylea-aflibercept-injection-data-presented-american-academy-ophthalmology-annual-meeting May 5, 2016
http://prnewswire.com/news-releases/eylea-aflibercept-injection-recommended-for-approval-for-the-treatment-of-visual-impairment-due-to-diabetic-macular-edema-in-the-european-union-264880011.html May 5, 2015
http://frenchbiobeach.com/join-our-email-list/page/11 April 4, 2016
http://thestreet.com/story/12160165/3/sanofi-regeneron-to-collaborate-with-american-college-of-cardiology-for-pcsk9-inhibitor-clinical-program.html January 1, 2015
http://prnewswire.com/news-releases/sanofi-and-regeneron-report-positive-top-line-results-with-alirocumab-from-first-phase-3-study-of-a-pcsk9-inhibitor-for-ldl-cholesterol-reduction-227948681.html April 4, 2015
http://biospace.com/news/regeneron-pharmaceuticals-inc-fda-accepts-sbla-for/318964/source=morenews January 1, 2015
http://thestreet.com/story/12040321/1/regeneron-to-present-phase-3-data-for-eylea-aflibercept-injection-in-diabetic-macular-edema-at-upcoming-retina-society-meeting.html May 5, 2016
http://thestreet.com/story/12021691/1/eylea-aflibercept-injection-approved-in-europe-for-the-treatment-of-visual-impairment-due-to-macular-edema-secondary-to-central-retinal-vein-occlusion.html October 10, 2016
http://prnewswire.com/news-releases/regeneron-highlights-eylea-aflibercept-injection-data-to-be-presented-at-american-academy-of-ophthalmology-annual-meeting-231629281.html January 1, 2015
http://prnewswire.com/news-releases/two-year-results-from-phase-3-vista-trial-of-eylea-aflibercept-injection-for-the-treatment-of-diabetic-macular-edema-show-sustained-improvement-in-vision-244696531.html February 2, 2015
http://biospace.com/news_story.aspx April 4, 2015
http://nj.com/business/prnewswire January 1, 2015
http://investor.regeneron.com/releaseDetail.cfm March 3, 2015
http://investor.regeneron.com/releasedetail.cfm May 5, 2015
http://thestreet.com/story/12466590/3/bayer-healthcare-and-regeneron-announce-regulatory-submission-of-eylea-aflibercept-injection-for-the-treatment-of-diabetic-macular-edema-in-japan.html May 5, 2015
http://bio-medicine.org/medicine-technology-1/sanofi-and-regeneron-report-positive-results-with-sarilumab-in-first-phase-3-rheumatoid-arthritis-registration-trial-37118-1 March 3, 2016
http://thestreet.com/story/11999721/1/regeneron-and-bayer-report-positive-one-year-results-from-two-phase-3-trials-of-eylea-aflibercept-injection-for-the-treatment-of-diabetic-macular-edema.html October 10, 2016
http://newsroom.regeneron.com/releasedetail.cfm April 4, 2015
20+ sources
http://prnewswire.com/news-releases/regeneron-reports-fourth-quarter-and-full-year-2012-financial-and-operating-results-191179371.html March 3, 2015
http://clinicaspace.com/news/sanofi-france-says-zaltrap-approved-in-europe-for/286672/source=yesterdaysmostpopular January 1, 2015
http://bio-medicine.org/medicine-technology-1/vegf-trap-eye-submitted-for-eu-marketing-authorization-for-treatment-of-wet-age-related-macular-degeneration-17903-1 March 3, 2016
http://bio-medicine.org/medicine-technology-1/regeneron-pharmaceuticals-announces-pricing-of-offering-of-convertible-senior-notes-due-october-1--2016-21180-1 March 3, 2016
http://drugs.com/clinical_trials/two-year-results-phase-3-studies-eylea-aflibercept-wet-amd-show-sustained-improvement-visual-acuity-12749.html March 3, 2016
http://biospace.com/news/regeneron-pharmaceuticals-inc-wins-fda-approval/241335 January 1, 2015
http://prnewswire.com/news-releases/regeneron-announces-receipt-of-hart-scott-rodino-notice-190674041.html January 1, 2015
http://prnewswire.com/news-releases/regeneron-reports-first-quarter-2012-financial-and-operating-results-149024265.html January 1, 2015
http://sanofi.de/l/de/de/layout.jsp August 8, 2015
http://br.sys-con.com/node/2534519 January 1, 2015
http://thestreet.com/story/11169001/2/eylea-aflibercept-injection-submitted-in-japan-for-marketing-authorization-for-the-treatment-of-wet-age-related-macular-degeneration.html March 3, 2016
http://drugs.com/clinical_trials/sanofi-regeneron-report-positive-phase-2b-trial-results-sarilumab-rheumatoid-arthritis-12112.html March 3, 2016
http://de.sys-con.com/node/2534519 March 3, 2016
http://drugs.com/clinical_trials/sanofi-aventis-regeneron-report-positive-phase-iii-results-zaltrap-aflibercept-second-line-11621.html March 3, 2016
http://biospace.com/collaborative/news/rockefeller-university-president-marc-tessier/241447 January 1, 2015
http://thestreet.com/story/11331461/5/two-year-results-of-phase-3-studies-with-eylea-aflibercept-injection-in-wet-amd-show-sustained-improvement-in-visual-acuity.html January 1, 2015
http://fiercebiotech.com/biotech/regeneron-announces-receipt-of-hart-scott-rodino-notice May 5, 2017
http://drugs.com/clinical_trials/sanofi-regeneron-report-phase-2-data-potential-first-class-lipid-lowering-pcsk9-antibody-13223.html May 5, 2017
http://au.sys-con.com/node/2534519 January 1, 2015
http://newsroom.regeneron.com/releasedetail.cfm July 7, 2015
http://prnewswire.com/news-releases/regeneron-reports-third-quarter-2012-financial-and-operating-results-175567551.html January 1, 2015
http://prnewswire.com/news-releases/regeneron-to-report-fourth-quarter-and-full-year-2012-financial-and-operating-results-and-host-conference-call-and-webcast-on-february-14-2013-188727991.html January 1, 2015
http://bio-medicine.org/medicine-technology-1/regeneron-announces-march-2011-investor-conference-presentations-14919-1 March 3, 2016
http://biospace.com/news_print.aspx May 5, 2015
http://drugs.com/clinical_trials/positive-phase-2b-results-sarilumab-rheumatoid-arthritis-presented-late-breaking-poster-2011-12563.html April 4, 2015
http://thenumbers.marketplace.org/publicradio/news/read/23130453/regeneron_recommends_rejection_of_mini April 4, 2015
http://bio-medicine.org/medicine-technology-1/regeneron-to-report-fourth-quarter-and-full-year-2012-financial-and-operating-results-and-host-conference-call-and-webcast-on-february-14--2013-29934-1 March 3, 2016
http://biospace.com/collaborative/News/regeneron-pharmaceuticals-inc-bayer-healthcare/242583 March 3, 2015
http://investor.regeneron.com/releasedetail.cfm July 7, 2015
http://biospace.com/news/regeneron-pharmaceuticals-inc-announces-upcoming/287954/source=morenews January 1, 2015
20+ sources
http://bio-medicine.org/medicine-technology-1/regeneron-announces-upcoming-2013-investor-conference-presentation-37394-1 January 1, 2015
http://prnewswire.com/news-releases/regeneron-reports-fourth-quarter-and-full-year-2012-financial-and-operating-results-191179371.html March 3, 2015
http://benzinga.com/pressreleases/12/11/n3097699/zaltrap-ziv-aflibercept-receives-chmp-positive-opinion-in-the-european- August 8, 2015
http://bio-medicine.org/medicine-news-1/regeneron-announces-presentation-at-the-21st-annual-piper-jaffray-healthcare-conference-62019-1 March 3, 2016
http://drugs.com/clinical_trials/sanofi-aventis-regeneron-announce-results-phase-2-study-aflibercept-vegf-trap-advanced-ovarian-7528.html March 3, 2016
http://biospace.com/news/regeneron-pharmaceuticals-inc-wins-fda-approval/241335 January 1, 2015
http://drugs.com/nda/zaltrap_120405.html March 3, 2016
http://drugs.com/news/phase-3-trial-aflibercept-metastatic-pancreatic-cancer-discontinued-19816.html March 3, 2016
http://prnewswire.com/news-releases/regeneron-announces-receipt-of-hart-scott-rodino-notice-190674041.html January 1, 2015
http://prnewswire.com/news-releases/regeneron-reports-first-quarter-2012-financial-and-operating-results-149024265.html January 1, 2015
http://br.sys-con.com/node/2534519 June 6, 2016
http://thestreet.com/story/11169001/2/eylea-aflibercept-injection-submitted-in-japan-for-marketing-authorization-for-the-treatment-of-wet-age-related-macular-degeneration.html March 3, 2016
http://sanofi.de/l/de/de/layout.jsp August 8, 2015
http://drugs.com/clinical_trials/positive-phase-2b-results-sarilumab-rheumatoid-arthritis-presented-late-breaking-poster-2011-12563.html April 4, 2015
http://multivu.com/mnr/57253-sanofi-fda-approves-zaltrap-ziv-aflibercept March 3, 2016
http://biospace.com/collaborative/news/rockefeller-university-president-marc-tessier/241447 January 1, 2015
http://bio-medicine.org/biology-technology-1/regeneron-announces-march-2012-investor-conference-presentations-21798-1 May 5, 2017
http://thestreet.com/story/11176767/2/phase-3-trial-of-zaltrap-aflibercept-in-advanced-prostate-cancer-to-continue-as-planned-at-recommendation-of-independent-data-monitoring-committee.html May 5, 2017
http://bio-medicine.org/medicine-technology-1/regeneron-to-report-fourth-quarter-and-full-year-2012-financial-and-operating-results-and-host-conference-call-and-webcast-on-february-14--2013-29934-1 May 5, 2017
http://thestreet.com/story/11964876/2/regeneron-announces-first-recipients-of-annual-regeneron-prize-for-creative-innovation.html August 8, 2015
http://drugs.com/clinical_trials/sanofi-regeneron-report-positive-phase-2b-trial-results-sarilumab-rheumatoid-arthritis-12112.html March 3, 2016
http://newsroom.regeneron.com/releasedetail.cfm July 7, 2015
http://prnewswire.com/news-releases/regeneron-to-report-fourth-quarter-and-full-year-2012-financial-and-operating-results-and-host-conference-call-and-webcast-on-february-14-2013-188727991.html January 1, 2015
http://thenumbers.marketplace.org/publicradio/news/read/23130453/regeneron_recommends_rejection_of_mini April 4, 2015
http://biospace.com/news/fda-advisers-reject-regeneron-pharmaceuticals-inc/259466 January 1, 2015
http://prnewswire.com/news-releases/regeneron-named-top-employer-in-the-global-biopharmaceutical-industry-for-the-second-year-in-a-row-229144571.html April 4, 2015
http://biospace.com/news_story.aspx February 2, 2015
http://theglobeandmail.com/globe-investor/news-sources July 7, 2015
http://biospace.com/news_print.aspx July 7, 2015
http://investor.regeneron.com/releasedetail.cfm July 7, 2015
20+ sources
http://tevapharm.com/news/teva_and_regeneron_announce_global_collaboration_to_develop_and_commercialize_fasinumab_an_investigational_ngf_antibody_for_chronic_pain_09_16.aspx October 10, 2016
http://mediaroom.sanofi.com/sanofi-sanofi-and-regeneron-announce-that-dupilumab-has-received-fda-breakthrough-therapy-designation-in-atopic-dermatitis-2 July 7, 2017
http://intelliatx.com/regeneron-intellia-therapeutics-announce-collaboration-discover-develop-crisprcas-therapeutics May 5, 2016
http://biotechstocks.com/regn-selected-by-society-for-science June 6, 2016
http://mediaroom.sanofi.com/sanofi-et-regeneron-annoncent-le-lancement-dune-etude-de-phase-3-du-dupilumab-dans-le-traitement-de-la-dermatite-atopique-2 July 7, 2017
http://prnewswire.com/news-releases/regeneron-genetics-center-and-geisinger-study-finds-life-threatening-genetic-disorder-is-substantially-underdiagnosed-300382688.html July 7, 2017
http://mediaroom.sanofi.com/sanofi-sanofi-et-regeneron-annoncent-les-resultats-positifs-dune-etude-de-phase-2b-du-dupilumab-chez-les-patients-souffrant-dasthme-modere-a-severe-2 May 5, 2017
http://prnewswire.com/news-releases/regeneron-ceo-leonard-schleifer-and-cso-george-yancopoulos-named-ey-2016-national-life-sciences-entrepreneurs-of-the-year-300366403.html July 7, 2017
http://fiercepharma.com/vaccines/regeneron-joins-human-vaccines-project-to-improve-global-disease-prevention-and-treatment November 11, 2016
http://medimmune.com/about-us/media/medimmune-and-regeneron-enter-into-licensing-agreement-for-the-development-of-antibody-drug-conjugates-to-treat-cancer-05042016.html June 6, 2016
http://intelliatx.com/category/news/page/3 March 3, 2017
http://arthritis.allaboutyourhealth.info/infectious-arthritis/regeneron-and-adicet-bio-announce-strategic-collaboration-to-discover-and-develop-next-generation-engineered.html September 9, 2016
http://marketwatchedz.tk/story/regeneron-and-inovio-enter-immuno-oncology-clinical-study-agreement-for-glioblastoma-combination-therapy-2017-05-08 July 7, 2017
http://marketwatchedz.tk/story/inovio-regeneron-enter-immuno-oncology-clinical-study-agreement-for-glioblastoma-combination-therapy-2017-05-08 July 7, 2017
http://marketwatchedz.tk/story/regeneron-announces-angptl3evinacumab-publication-in-new-england-journal-of-medicine-and-positive-phase-2-data-in-people-with-hofh-2017-05-24 July 7, 2017
http://marketwatchedz.tk/story/regeneron-recognized-on-the-civic-50-list-of-the-most-community-minded-companies-in-the-united-states-2017-06-21 July 7, 2017
http://marketwatchedz.tk/story/regeneron-details-royalty-agreement-with-novartis-for-canakinumab-acz885-2017-06-22 July 7, 2017
http://societyforscience.org/content/press-room/regeneron September 9, 2016
http://cmarketwatchez.tk/story/regeneron-announces-angptl3evinacumab-publication-in-new-england-journal-of-medicine-and-positive-phase-2-data-in-people-with-hofh-2017-05-24 May 5, 2017
http://cmarketwatchez.tk/story/regeneron-and-inovio-enter-immuno-oncology-clinical-study-agreement-for-glioblastoma-combination-therapy-2017-05-08 May 5, 2017
http://cmarketwatchez.tk/story/inovio-regeneron-enter-immuno-oncology-clinical-study-agreement-for-glioblastoma-combination-therapy-2017-05-08 May 5, 2017
http://ariva.de/news/regeneron-and-teva-announce-global-collaboration-to-develop-5884164 December 12, 2016
http://buzzstake.com/regeneron-and-intellia-therapeutics-announce-collaboration-to-discover-and-develop-crisprcas-therapeutics April 4, 2016
http://intelliatx.com/category/news/page/2 January 1, 2017
http://prweb.com/releases/2016/02/prweb13208560.htm May 5, 2017
http://intelliatx.com/category/news May 5, 2016
http://biotechstocks.com/tag/biotech-stocks/page/2 June 6, 2016
http://biotechstocks.com/category/biotech-stocks-news/page/2 June 6, 2016
http://biotechstocks.com/tag/best-biotech-stocks/page/2 June 6, 2016
http://biotechstocks.com/tag/biotech-industry-news/page/2 June 6, 2016
20+ sources
http://pharmalive.com/regeneron-and-sanofi-announce-approval-of-praluent-alirocumab-for-the-treatment-of-hypercholesterolemia-in-the-european-union May 5, 2016
http://labourseetlavie.com/actualites-economiques-et-financieres-actualites/sanofi-et-regeneron-annoncent-lapprobation-au-japon-de-praluent-alirocumab-dans-le-traitement-de-lhypercholesterolemie November 11, 2016
http://news.genzyme.com/press-release/sanofi-and-regeneron-announce-first-approval-kevzaratm-sarilumab-treatment-moderately- February 2, 2017
http://news.genzyme.com/press-release/sanofi-and-regeneron-present-results-phase-3-monarch-study-investigational-sarilumab-a February 2, 2017
http://asianhhm.com/pressreleases/regeneron-and-sanofi-announce-approval-of-praluent-alirocumab-for-the-treatment-of-hypercholesterolemia-in-the-european-union September 9, 2015
http://wallstreet-online.de/nachricht/8243085-sanofi-and-regeneron-announce-sarilumab-biologics-license-application-accepted-for-review-by-us-fda December 12, 2016
http://news.sanofigenzyme.com/print/node/3417 February 2, 2017
http://news.sanofigenzyme.com/press-release/sanofi-and-regeneron-announce-first-approval-kevzaratm-sarilumab-treatment-moderately- February 2, 2017
http://life-sciences-france.com/product/praluent-sanofi-euronext-san-nyse-sny-group-since-2001-25136.html June 6, 2016
http://fiercepharma.com/marketing/sanofi-and-regeneron-announce-topline-results-of-phase-3-monotherapy-study-demonstrating November 11, 2016
http://euroinvestor.fr/actualites/2017/02/08/sanofi-la-cour-dappel-accorde-la-supension-de-linjonction-permanente-visant-praluent-alirocumab-pendant-la-duree-de-la-procedure-dappel/13528975 February 2, 2017
http://medindia.net/health-press-release/regeneron-presents-positive-interim-data-from-phase-2-proof-of-concept-study-of-evinacumab-in-patients-with-homozygous-familial--289572-1.htm November 11, 2016
http://life-sciences-france.com/news/sanofi-regeneron-receive-complete-euronext-san-nyse-sny-2001-109248.html November 11, 2016
http://life-sciences-france.com/product/sarilumab-sanofi-euronext-san-nyse-sny-group-since-2001-25591.html June 6, 2016
http://pharmalive.com/regeneron-and-sanofi-announce-approval-of-praluent-alirocumab-for-the-treatment-of-hypercholesterolemia-in-the-european-union/ September 9, 2015
http://news.sanofigenzyme.com/press-release/sanofi-and-regeneron-present-results-phase-3-monarch-study-investigational-sarilumab-a February 2, 2017
http://news.sanofigenzyme.com/press-release/sanofi-and-regeneron-receive-complete-response-letter-fda-sarilumab-investigational-tr February 2, 2017
http://news.sanofigenzyme.com/print/node/3438 February 2, 2017
http://prnewswire.com/news-releases/regeneron-and-sanofi-announce-praluent-alirocumab-marketing-authorization-application-has-been-accepted-for-review-by-ema-300018715.html October 10, 2016
http://biotechstocks.com/tag/best-biotech-stocks June 6, 2016
http://biotechstocks.com/tag/biotech-stock-news June 6, 2016
http://biotechstocks.com/regn-presents-positive-interim-data June 6, 2016
http://biotechstocks.com/category/biotech-stocks-news June 6, 2016
http://biotechstocks.com/tag/biotech-industry-news June 6, 2016
http://news.genzyme.com/print/node/3268 June 6, 2016
http://news.genzyme.com/press-release/sanofi-and-regeneron-announce-topline-results-phase-3-monotherapy-study-demonstrating- June 6, 2016
http://prnewswire.com/news-releases/sanofi-and-regeneron-announce-unitedhealth-group-selects-praluent-alirocumab-injection-for-preferred-access-300191648.html October 10, 2016
http://fiercebiotech.com/biotech/regeneron-and-sanofi-announce-sarilumab-biologics-license-application-accepted-for-review December 12, 2016
http://research-tree.com/newsfeed/newsrelease/60500 March 3, 2016
http://asianhhm.com/prnews/regeneron-and-sanofi-announce-approval-of-praluent-alirocumab-for-the-treatment-of-hypercholesterolemia-in-the-european-union September 9, 2015
19 sources
http://news.genzyme.com/print/node/3244 February 2, 2016
http://benzinga.com/pressreleases/16/10/n8517612/regeneron-and-sanofi-announce-positive-dupixent-dupilumab-phase-3-atopi July 7, 2017
http://prnewswire.com/news-releases/new-survey-reveals-the-widespread-and-serious-impact-of-moderate-to-severe-atopic-dermatitis-on-people-living-with-the-disease-300339444.html July 7, 2017
http://mediaroom.sanofi.com/sanofi-and-regeneron-announce-positive-dupilumab-topline-results-from-two-phase-3-trials-in-inadequately-controlled-moderate-to-severe-atopic-dermatitis-patients May 5, 2017
http://mediaroom.sanofi.com/sanofi-and-regeneron-announce-dupilumab-biologics-license-application-accepted-for-priority-review-by-u-s-fda May 5, 2017
http://pharmafocusasia.com/pressreleases/regeneron-announces-eu-approval-of-eylea-aflibercept-injection-for-the-treatment-of-visual-impairment-secondary-to-myopic-choroidal-neovascularization January 1, 2016
http://news.genzyme.com/press-release/sanofi-and-regeneron-announce-publication-positive-phase-2-dupilumab-data-journal-amer February 2, 2016
http://prnewswire.com/news-releases/sanofi-and-regeneron-to-present-new-data-on-dupixent-dupilumab-for-moderate-to-severe-atopic-dermatitis-at-upcoming-medical-congresses-300413658.html July 7, 2017
http://news.sanofigenzyme.com/print/node/3422 February 2, 2017
http://retinalinkglobal.com/regeneron-announces-important-us-prescribing-information-clarification-eylea-aflibercept-injection August 8, 2016
http://life-sciences-france.com/news/sanofi-regeneron-ph3-results-euronext-san-nyse-sny-2001-107702.html June 6, 2016
http://prnewswire.com/news-releases/eylea-aflibercept-injection-receives-approval-in-japan-for-the-treatment-of-retinal-vein-occlusion-300105348.html May 5, 2017
http://news.sanofigenzyme.com/press-release/sanofi-and-regeneron-announce-marketing-authorization-application-dupixent-dupilumab-a February 2, 2017
http://news.sanofigenzyme.com/press-release/new-survey-reveals-widespread-and-serious-impact-moderate-severe-atopic-dermatitis-peo February 2, 2017
http://news.sanofigenzyme.com/press-release/sanofi-and-regeneron-announce-positive-dupixent-dupilumab-phase-3-atopic-dermatitis-da February 2, 2017
http://news.sanofigenzyme.com/press-release/sanofi-and-regeneron-announce-dupilumab-biologics-license-application-accepted-priorit February 2, 2017
http://news.genzyme.com/print/node/3320 June 6, 2016
http://news.genzyme.com/press-release/sanofi-and-regeneron-announce-positive-dupilumab-topline-results-two-phase-3-trials-in June 6, 2016
http://news.genzyme.com/press-release/sanofi-and-regeneron-announce-dupilumab-used-topical-corticosteroids-tcs-was-superior- June 6, 2016
20+ sources
http://bio-medicine.org/medicine-technology-1/regeneron-announces-upcoming-2013-investor-conference-presentation-37394-1 January 1, 2015
http://prnewswire.com/news-releases/sanofi-and-regeneron-to-present-alirocumab-clinical-data-at-the-american-college-of-cardiologys-63rd-annual-scientific-session-252586521.html May 5, 2015
http://benzinga.com/pressreleases/12/11/n3097699/zaltrap-ziv-aflibercept-receives-chmp-positive-opinion-in-the-european- August 8, 2015
http://news.genzyme.com/print/node/3244 February 2, 2016
http://drugs.com/nda/zaltrap_120405.html April 4, 2015
http://biospace.com/news/sanofi-france-and-regeneron-pharmaceuticals-inc/319187 March 3, 2016
http://prnewswire.com/news-releases/eylea-aflibercept-injection-recommended-for-approval-for-the-treatment-of-visual-impairment-due-to-diabetic-macular-edema-in-the-european-union-264880011.html May 5, 2015
http://wallstreet-online.de/nachricht/8243085-sanofi-and-regeneron-announce-sarilumab-biologics-license-application-accepted-for-review-by-us-fda May 5, 2017
http://news.genzyme.com/press-release/sanofi-and-regeneron-announce-publication-positive-phase-2-dupilumab-data-journal-amer February 2, 2016
http://bio-medicine.org/biology-technology-1/regeneron-to-report-second-quarter-2014-financial-and-operating-results-and-host-conference-call-and-webcast-on-august-5--2014-29571-1 May 5, 2017
http://biospace.com/collaborative/News/regeneron-pharmaceuticals-inc-named-worlds-1/273966 March 3, 2015
http://sec.gov/archives/edgar/data/872589/000153217614000034/exhibit991q22014.htm August 8, 2015
http://asianhhm.com/pressreleases/regeneron-and-sanofi-announce-approval-of-praluent-alirocumab-for-the-treatment-of-hypercholesterolemia-in-the-european-union March 3, 2016
http://asianhhm.com/prnews/regeneron-and-sanofi-announce-approval-of-praluent-alirocumab-for-the-treatment-of-hypercholesterolemia-in-the-european-union March 3, 2016
http://clinicaspace.com/news/sanofi-france-says-zaltrap-approved-in-europe-for/286672/source=yesterdaysmostpopular January 1, 2015
http://thestreet.com/story/12040321/1/regeneron-to-present-phase-3-data-for-eylea-aflibercept-injection-in-diabetic-macular-edema-at-upcoming-retina-society-meeting.html May 5, 2017
http://multivu.com/mnr/57253-sanofi-fda-approves-zaltrap-ziv-aflibercept March 3, 2016
http://prnewswire.com/news-releases/regeneron-highlights-eylea-aflibercept-injection-data-to-be-presented-at-american-academy-of-ophthalmology-annual-meeting-231629281.html January 1, 2015
http://fiercebiotech.com/biotech/regeneron-and-sanofi-announce-sarilumab-biologics-license-application-accepted-for-review May 5, 2017
http://bio-medicine.org/medicine-technology-1/sanofi-and-regeneron-report-positive-results-with-sarilumab-in-first-phase-3-rheumatoid-arthritis-registration-trial-37118-1 March 3, 2016
http://prnewswire.com/news-releases/regeneron-named-top-employer-in-the-global-biopharmaceutical-industry-for-the-second-year-in-a-row-229144571.html April 4, 2015
http://biospace.com/news/fda-advisers-reject-regeneron-pharmaceuticals-inc/259466 January 1, 2015
http://investor.regeneron.com/releasedetail.cfm May 5, 2015
http://prnewswire.com/news-releases/regeneron-reports-second-quarter-2014-financial-and-operating-results-269955161.html May 5, 2015
http://biospace.com/news_story.aspx April 4, 2015
http://clinicaspace.com/news/sanofi-france-unveils-mixed-news-for-zaltrap/255537/source=topbreaking January 1, 2015
http://newsroom.regeneron.com/releasedetail.cfm April 4, 2015
http://theglobeandmail.com/globe-investor/news-sources July 7, 2015
http://biospace.com/news_print.aspx July 7, 2015
http://pharmafocusasia.com/pressreleases/regeneron-announces-eu-approval-of-eylea-aflibercept-injection-for-the-treatment-of-visual-impairment-secondary-to-myopic-choroidal-neovascularization January 1, 2016
20+ sources
http://biospace.com/news/regeneron-pharmaceuticals-inc-announces-winners-of/335722 January 1, 2015
http://mediaroom.sanofi.com/sanofi-et-regeneron-prevoient-dutiliser-un-droit-dacces-a-un-examen-prioritaire-pour-la-demande-dapprobation-dalirocumab-aupres-de-la-fda-des-etats-unis-2 May 5, 2017
http://mediaroom.sanofi.com/sanofi-sanofi-and-regeneron-announce-positive-results-from-phase-2b-study-of-dupilumab-in-patients-with-moderate-to-severe-atopic-dermatitis-2 June 6, 2017
http://bio-medicine.org/biology-technology-1/regeneron-and-sanofi-announce-plan-to-use-priority-review-voucher-for-alirocumab-u-s--fda-submission-29759-1 April 4, 2016
http://prnewswire.com/news-releases/regeneron-announces-upcoming-2014-investor-conference-presentations-271835731.html July 7, 2015
http://thestreet.com/story/12769643/1/sanofi-and-regeneron-announce-positive-results-from-phase-2b-study-of-dupilumab-in-patients-with-moderate-to-severe-atopic-dermatitis.html November 11, 2016
http://thestreet.com/story/12849993/1/regeneron-pharmaceuticals-inc-nasdaq-regn-to-ring-the-nasdaq-stock-market-opening-bell.html January 1, 2015
http://mediaroom.sanofi.com/sanofi-et-regeneron-annoncent-lapprobation-de-praluent-alirocumab-dans-lunion-europeenne-pour-le-traitement-de-lhypercholesterolemie-2 May 5, 2017
http://mediaroom.sanofi.com/sanofi-and-regeneron-announce-new-positive-praluent-alirocumab-phase-3-data-presented-at-esc-congress-2015-2 May 5, 2017
http://freshnews.com/regeneron-and-teva-provide-update-on-fasinumab-clinical-development-programs/20161017 October 10, 2016
http://sanoficanada.mediaroom.com/2015-09-01-sanofi-and-regeneron-announce-new-positive-praluent-alirocumab-phase-3-data-presented-at-esc-congress-2015 June 6, 2016
http://bio-medicine.org/medicine-technology-1/regeneron-and-sanofi-to-present-results-from-four-phase-3-alirocumab-trials-in-hot-line-session-at-esc-congress-2014-39446-1 April 4, 2016
http://bio-medicine.org/biology-technology-1/regeneron-to-report-second-quarter-2014-financial-and-operating-results-and-host-conference-call-and-webcast-on-august-5--2014-29571-1 January 1, 2015
http://streetinsider.com/press+releases/regeneron+announces+presentation+at+the+25th+annual+credit+suisse+healthcare+conference/12154305.html October 10, 2016
http://prnewswire.com/news-releases/regeneron-and-sanofi-to-present-results-from-four-phase-3-alirocumab-trials-in-hot-line-session-at-esc-congress-2014-272525111.html April 4, 2015
http://prnewswire.com/news-releases/regeneron-and-sanofi-announce-presentation-of-detailed-positive-results-from-four-pivotal-alirocumab-trials-at-esc-congress-2014-273358761.html May 5, 2015
http://benzinga.com/pressreleases/14/08/n4755431/regeneron-reports-second-quarter-2014-financial-and-operating-results November 11, 2016
http://sanoficanada.fr.mediaroom.com/2015-09-01-sanofi-et-regeneron-annoncent-la-pr-sentation-de-nouvelles-donn-es-positives-de-phase-3-de-praluent-alirocumab-au-congr-s-2015-de-lesc November 11, 2016
http://globenewswire.com/news-release/2014/07/09/649763/10088795/en/sanofi-and-regeneron-announce-positive-results-from-phase-2b-study-of-dupilumab-in-patients-with-moderate-to-severe-atopic-dermatitis.html January 1, 2015
http://bio-medicine.org/biology-technology-1/regeneron-and-sanofi-announce-plan-to-use-priority-review-voucher-for-alirocumab-u-s--fda-submission-29759-6 January 1, 2015
http://theglobeandmail.com/globe-investor/news-sources January 1, 2015
http://bio-medicine.org/biology-technology-1/Regeneron-and-Sanofi-Announce-Plan-to-Use-Priority-Review-Voucher-For-Alirocumab-U-S--FDA-Submission-29759-6 March 3, 2015
http://sec.gov/archives/edgar/data/872589/000153217614000034/exhibit991q22014.htm January 1, 2015
http://biospace.com/news_story.aspx May 5, 2015
http://health-fitness.news-articles.net/content/regeneron-announces-upcoming-investor-conference-presentation.xhtml November 11, 2016
http://biospace.com/News/regeneron-pharmaceuticals-inc-announces-winners-of/335722 April 4, 2015
http://prnewswire.com/news-releases/regeneron-reports-second-quarter-2014-financial-and-operating-results-269955161.html May 5, 2015
http://nationaleczema.org/regeneron-sanofi-announce-positive-results February 2, 2015
http://prnewswire.com/news-releases/regeneron-announces-update-to-upcoming-2014-investor-conference-presentations-261291521.html April 4, 2015
http://pharmafocusasia.com/pressreleases/regeneron-announces-upcoming-2015-investor-conference-presentations January 1, 2016
19 sources
http://drugs.com/clinical_trials/regeneron-announces-positive-results-exploratory-proof-concept-study-rilonacept-chronic-active-gout-1904.html January 1, 2015
http://drugs.com/clinical_trials/vegf-trap-eye-shows-positive-results-phase-2-study-patients-diabetic-macular-edema-8883.html April 4, 2015
http://bio-medicine.org/medicine-news-1/regeneron-announces-presentation-at-the-21st-annual-piper-jaffray-healthcare-conference-62019-1 April 4, 2014
http://medindia.net/health-press-release/regeneron-announces-participation-in-a-panel-discussion-at-rbc-capital-markets-healthcare-conference-62072-1.htm July 7, 2017
http://bio-medicine.org/medicine-technology-1/regeneron-announces-presentation-at-the-deutsche-bank-2009-biotech-boston-confab-6892-1 January 1, 2015
http://bio-medicine.org/medicine-news-1/regeneron-announces-september-2009-investment-conference-presentations-56871-1 May 5, 2017
http://drugs.com/clinical_trials/sanofi-aventis-regeneron-announce-results-phase-2-study-aflibercept-vegf-trap-advanced-ovarian-7528.html January 1, 2015
http://bio-medicine.org/medicine-technology-1/phase-3-trial-of-aflibercept-in-metastatic-pancreatic-cancer-discontinued-4975-5 February 2, 2015
http://drugs.com/clinical_trials/regeneron-bayer-healthcare-announce-vegf-trap-eye-achieved-durable-improvement-vision-over-52-weeks-5314.html February 2, 2015
http://investor.regeneron.com/releasedetail.cfm July 7, 2015
http://biospace.com/news/regeneron-pharmaceuticals-inc-jobs-sanofi-aventis/162454 January 1, 2015
http://redorbit.com/news/health/1751937/phase_3_trial_of_aflibercept_in_metastatic_pancreatic_cancer_discontinued January 1, 2015
http://bowhuntingoutlet.com/scent-eliminators/wildlife-research-center-inc March 3, 2015
http://en.wikipedia.org/wiki/Marshall,_Missouri March 3, 2015
http://redorbit.com/news/health/1752433/enrollment_completed_in_regeneron_and_bayer_healthcare_phase_3_studies April 4, 2014
http://newsroom.regeneron.com/releasedetail.cfm April 4, 2015
http://bio-medicine.org/medicine-news-1/regeneron-announces-september-2009-investment-conference-presentations-56871-2 January 1, 2015
http://drugs.com/news/regeneron-closes-312-million-common-stock-sale-connection-sanofi-aventis-collaboration-7451.html April 4, 2015
http://johnlewis.scene7.com/is/image/JohnLewis/000403487 April 4, 2015
1 source
http://mediaroom.sanofi.com/sanofi-et-regeneron-annoncent-lapprobation-de-praluent-alirocumab-dans-lunion-europeenne-pour-le-traitement-de-lhypercholesterolemie-2 May 5, 2017

Please log in to uncover the email addresses, access the 288 results for regeneron.com, filters and more.

Create a free account

Already have an account? Sign in

More information about regeneron.com

Language of the website: English

Main technologies used:

Find email addresses from any website

Search contact information of any website in one click.

When you visit a website, click on the icon to find the email addresses related to the website.

image/svg+xml

Hunter is the easiest way to find the email address of any professional. Search any domain name to find instantly the main email format used in an organization and all the email addresses publicly available on the web.


Homepage • Companies directory